-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
Mid-Week Break
Our regular posts will resume tomorrow.
-
NIH Opens $1M Maternal Health Diagnostics Challenge
National Institutes of Health began a competition for low-cost diagnostic technologies to improve maternal health, particularly in low-resource regions.
-
Trial Shows Nasal Spray Relieves Migraine Pain
Clinical trial results show a nasal spray treatment for acute migraine helps more users achieve relief from pain within two hours, and faster in some cases.
-
Infographic – Huge Quantum Computing Growth Forecast
Quantum computing is expected to make major gains in this decade, with the global market size for this technology accelerating in that time.
-
AI-Aided Fall Prevention System Gains $30M in New Funds
A developer of a system using artificial intelligence to process video for preventing falls by older people is raising $30 million in its second venture round.
-
Oxford, GSK Partner on New Tech for Neuro Diseases
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders.
-
$180M Venture Fund Backing Age-Related Disease Start-Ups
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics.
-
Patent Awarded for Opioid Risk System with Geographic Data
A company analyzing public health data by geography and social factors received a patent for its system identifying likely opioid addiction hot spots.
-
Covid-19 Antibody Cocktail Trial Request Filed
A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy.